Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
3
×
biotech
3
×
clinical trials
fda
life sciences
national
3
×
national blog main
san francisco blog main
san francisco top stories
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
calcitonin gene-related peptide
detroit blog main
detroit top stories
eli lilly
eptinezumab
erenumab
fremanezumab
galcanezumab
indiana blog main
indiana top stories
migraine research foundation
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
teva pharmaceutical
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abaloparatide
alder biopharmaceutical
What
approval
3
×
drug
amgen
class
developed
fda
migraine
new
nod
won
amgen’s
arguments
big
candidates
carries
commercialized
companies
competitors
decades
drugs
europe
european
gets
head
heart
make
marketing
medicine
medicines
meeting
neuro
oral
osteoporosis
pain
potential
preventive
raise
risk
starts
therapies
Language
unset
Current search:
national
×
biotech
×
approval
×
amgen
×
@xconomy.com
4 years ago
Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
6 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines